(May 22, 2020, 1:36 PM EDT) -- WILMINGTON, Del. — Drug manufacturer Akorn Inc. on May 20 filed a voluntary petition for reorganization under federal bankruptcy laws, saying it has agreed to an “in-court sale” of its business that will address “litigation-related overhangs” (In Re: Akorn, Inc., No. 20-11177, D. Del. Bkcy.)....